Deutsche Bank
TVRD

Deutsche Bank’s Tvardi Therapeutics TVRD Stock Holding History

Deutsche Bank’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.63K Hold
3,030
– – ﹤0.01% 3554
2025
Q4 		$13K Hold
3,030
– – ﹤0.01% 3542
2025
Q3 		$118K Hold
3,030
– – ﹤0.01% 3278
2025
Q2 		$70.7K Buy
+3,030
New +$71.6K ﹤0.01% 3363
2023
Q4 		– Sell
-805
Closed -$48.7K – 3726
2023
Q3 		$48.7K Hold
805
– – ﹤0.01% 3418
2023
Q2 		$82K Sell
805
-109
-12% -$15K ﹤0.01% 3353
2023
Q1 		$162K Buy
914
+247
+37% +$82.7K ﹤0.01% 3106
2022
Q4 		$258K Buy
667
+131
+24% +$49.8K ﹤0.01% 2820
2022
Q3 		$181K Sell
536
-79
-13% -$28.6K ﹤0.01% 2998
2022
Q2 		$203K Sell
615
-68
-10% -$23.9K ﹤0.01% 3162
2022
Q1 		$299K Sell
683
-75
-10% -$30.8K ﹤0.01% 3042
2021
Q4 		$332K Buy
758
+48
+7% +$24.1K ﹤0.01% 3085
2021
Q3 		$395K Sell
710
-2,800
-80% -$1.4M ﹤0.01% 3185
2021
Q2 		$1.8M Sell
3,510
-1,474
-30% -$934K ﹤0.01% 2326
2021
Q1 		$3.9M Buy
4,984
+4,128
+482% +$2.83M ﹤0.01% 1697
2020
Q4 		$467K Sell
856
-734
-46% -$385K ﹤0.01% 2953
2020
Q3 		$728K Buy
1,590
+998
+169% +$580K ﹤0.01% 2403
2020
Q2 		$364K Buy
592
+212
+56% +$117K ﹤0.01% 2807
2020
Q1 		$181K Sell
380
-21
-5% -$11.4K ﹤0.01% 2997
2019
Q4 		$231K Buy
401
+90
+29% +$63.2K ﹤0.01% 3134
2019
Q3 		$204K Buy
311
+30
+11% +$24.9K ﹤0.01% 3182
2019
Q2 		$216K Sell
281
-10
-3% -$7.03K ﹤0.01% 3770
2019
Q1 		$203K Sell
291
-8,158
-97% -$4.88M ﹤0.01% 3993
2018
Q4 		$3.95M Buy
8,449
+1,958
+30% +$1.26M ﹤0.01% 1946
2018
Q3 		$5.6M Sell
6,491
-4,957
-43% -$3.58M ﹤0.01% 2097
2018
Q2 		$7.89M Buy
11,448
+6,887
+151% +$3.5M ﹤0.01% 1943
2018
Q1 		$2.03M Buy
4,561
+2,494
+121% +$1.21M ﹤0.01% 2857
2017
Q4 		$908K Sell
2,067
-2,071
-50% -$944K ﹤0.01% 3259
2017
Q3 		$2.04M Buy
4,138
+1,255
+44% +$628K ﹤0.01% 2523
2017
Q2 		$1.59M Buy
2,883
+2,389
+484% +$1.52M ﹤0.01% 2704
2017
Q1 		$326K Sell
494
-187
-27% -$99.9K ﹤0.01% 3328
2016
Q4 		$226K Sell
681
-2,130
-76% -$684K ﹤0.01% 3607
2016
Q3 		$843K Buy
2,811
+2,459
+699% +$533K ﹤0.01% 2934
2016
Q2 		$60K Sell
352
-804
-70% -$175K ﹤0.01% 4339
2016
Q1 		$258K Buy
1,156
+948
+456% +$283K ﹤0.01% 3535
2015
Q4 		$125K Sell
208
-2,065
-91% -$1.13M ﹤0.01% 3961
2015
Q3 		$1.17M Buy
2,273
+2,161
+1,929% +$1.45M ﹤0.01% 2840
2015
Q2 		$48K Sell
112
-2,261
-95% -$874K ﹤0.01% 4611
2015
Q1 		$858K Buy
2,373
+2,041
+615% +$772K ﹤0.01% 2962
2014
Q4 		$118K Buy
332
+331
+33,100% +$107K ﹤0.01% 4619
2014
Q3 		$0 Sell
1
-73
-99% -$30K ﹤0.01% 6114
2014
Q2 		$45K Buy
74
+37
+100% +$19.9K ﹤0.01% 4980
2014
Q1 		$24K Buy
+37
New +$21.9K ﹤0.01% 4787

Other funds holding TVRD

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return

Deutsche Bank's TVRD Position: Q1 2026 in Review

Deutsche Bank held its Tvardi Therapeutics (TVRD) position steady in Q1 2026 at 3,030 shares worth $9.63K. The position accounts for ﹤0.01% of the portfolio, ranked #3554.

Deutsche Bank first reported a position in TVRD in Q1 2014 and has held it in 43 quarters since. The position peaked at $7.89M in Q2 2018. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.

  • Deutsche Bank held 3,030 shares of Tvardi Therapeutics worth $9.63K as of Q1 2026.
  • Deutsche Bank left its Tvardi Therapeutics share count unchanged in Q1 2026.
  • Tvardi Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3554 holding.
  • Deutsche Bank first reported a position in Tvardi Therapeutics in Q1 2014 and has held it in 43 quarters since.
  • Deutsche Bank's Tvardi Therapeutics position peaked at $7.89M in Q2 2018.
  • 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.